1-3 of 3
Anne-Sophie Chretien
Close
Sort by
Journal Articles

5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions

Anne-Charlotte Le Floch, Elisabeth Wieduwild, Anne-Sophie Chretien, Florence Orlanducci, Céline Garulli, Sarah Bourass, Caroline Imbert, Aude De Gassart, Norbert Vey, Loui Madakamutil, Daniel Olive
Journal: Blood
Blood (2022) 140 (Supplement 1): 11535–11536.
https://doi.org/10.1182/blood-2022-165161
Published: 2022
Journal Articles

Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study

Raynier Devillier, Sabine Furst, Agnes boyer Chammard, Thomas Pagliardini, Samia Harbi, Valerio Maisano, Angela Granata, Faezeh Legrand, Jihane Pakradouni, jean Marie Boher, Cyril Fauriat, Anne-Sophie Chretien, Christian Chabannon, Norbert Vey, Eric Vivier, Daniel Olive, Didier Blaise
Journal: Blood
Blood (2021) 138 (Supplement 1): 1817.
https://doi.org/10.1182/blood-2021-150730
Published: 2021
Journal Articles

Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts

Anne-Charlotte Le Floch, MBBS, MSc, Florence Orlanducci, Antoine Briantais, Aude Le Roy, Anne-Sophie Chretien, Norbert Vey, MD PhD, Daniel Olive, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5153.
https://doi.org/10.1182/blood-2019-125541
Published: 2019